Literature DB >> 8985212

The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.

C A Sabin1, P Telfer, A N Phillips, S Bhagani, C A Lee.   

Abstract

Patients coinfected with both hepatitis C virus (HCV) and the human immunodeficiency virus (HIV) have more rapid progression of HCV infection; however, little is known about the effect of coinfection with HCV on the progression of HIV disease. This study assessed the association between infection with different HCV genotypes on progression to AIDS and death in a cohort of men with hemophilia. Patients infected with HCV type 1 experienced a more rapid progression to both AIDS (P = .009) and death (P = .007) than did those infected with other types. This effect was largely independent of age at seroconversion, hemophilia diagnosis, and changes in CD4 cell count over the follow-up period. These results suggest an association between HCV genotype and progression of HIV disease, which, if confirmed, could have important implications for the treatment and care of patients coinfected with both HIV and HCV.

Entities:  

Mesh:

Year:  1997        PMID: 8985212     DOI: 10.1093/infdis/175.1.164

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Update on Hepatitis B and C Coinfection in HIV.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

2.  Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count.

Authors:  S Mauss; H Klinker; A Ulmer; R Willers; B Weissbrich; H Albrecht; D Häussinger; H Jablonowski
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

3.  Management of Hepatitis C in HIV-infected Patients.

Authors:  Benigno Rodriguez; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

4.  Seroprevalence of cytomegalovirus, Toxoplasma gondii, syphilis, and hepatitis B and C virus infections in a regional population seropositive for HIV infection.

Authors:  D G Johns; M J Gill
Journal:  Can J Infect Dis       Date:  1998-07

5.  Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects.

Authors:  Harriet Mayanja Kizza; Benigno Rodriguez; Miguel Quinones-Mateu; Muneer Mirza; Htin Aung; Belinda Yen-Lieberman; Colleen Starkey; Libby Horter; Pierre Peters; Joy Baseke; John L Johnson; Zahra Toossi
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

6.  Clinical variables identify seronegative HCV co-infection in HIV-infected individuals.

Authors:  Ajay R Bharti; Scott L Letendre; Tanya Wolfson; David Clifford; Ann C Collier; Benjamin Gelman; Justin McArthur; Christina Marra; Allen McCutchan; Susan Morgello; David Simpson; Ron J Ellis; Igor Grant
Journal:  J Clin Virol       Date:  2011-09-15       Impact factor: 3.168

7.  Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.

Authors:  Lena Al-Harthi; John Voris; Wenbo Du; David Wright; Marek Nowicki; Toni Frederick; Alan Landay; Andrea Kovacs
Journal:  J Infect Dis       Date:  2006-03-17       Impact factor: 5.226

Review 8.  Hepatitis C virus infection in children coinfected with HIV: epidemiology and management.

Authors:  Massimo Resti; Chiara Azzari; Flavia Bortolotti
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China.

Authors:  Hong Shang; Ping Zhong; Jing Liu; Xiaoxu Han; Di Dai; Min Zhang; Ke Zhao; Rongzhen Xu; Xiao-Fang Yu
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

10.  Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China.

Authors:  Rebecca-J Garten; Sheng-Han Lai; Jin-Bing Zhang; Wei Liu; Jie Chen; Xiao-Fang Yu
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.